CSIMarket
 


Neurotrope inc   (NTRP)
Other Ticker:  
 
 

NTRP's Free Cash Flow Growth by Quarter and Year

Neurotrope Inc 's Free Cash Flow results by quarter and year




NTRP Free Cash Flow (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -1.52 -1.33 -2.54
III Quarter September -3.25 -2.73 -2.08 -2.82
II Quarter June -1.91 -2.82 -2.68 -2.45
I Quarter March -1.74 -4.82 -1.62 -3.18
FY   -6.90 -11.89 -7.71 -10.99



NTRP Free Cash Flow third quarter 2020 Y/Y Growth Comment
Neurotrope inc in the third quarter 2020 recorded free cash outflow of $ -3.25 millions.

According to the results reported in the third quarter 2020, Neurotrope Inc achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Neurotrope Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2020.




NTRP Free Cash Flow ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Neurotrope Inc 's third quarter 2020 Free Cash Flow $ -3.25 millions NTRP's Income Statement
Neurotrope Inc 's third quarter 2019 Free Cash Flow $ -2.73 millions Quarterly NTRP's Income Statement
New: More NTRP's historic Free Cash Flow Growth >>


NTRP Free Cash Flow (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Neurotrope Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRP's III. Quarter Q/Q Free Cash Flow Comment
III. Quarter 2020 accomplishment of -3.25 millions by Neurotrope inc look even worse compare to the free cash outflow -1.91 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Neurotrope inc achieved highest sequential Free Cash Flow growth. While Neurotrope Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRP's III. Quarter Q/Q Free Cash Flow Comment
Current results of -3.25 millions by Neurotrope inc appear even more unfavourable considering the free cash outflow -1.91 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Neurotrope inc achieved highest sequential Free Cash Flow growth. While Neurotrope Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Neurotrope Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Free Cash Flow 12 Months Ending $ -8.42 $ -7.89 $ -8.81 $ -11.89 $ -11.69
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment


Neurotrope inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment


Neurotrope inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
NTRP's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for NTRP's Competitors
Free Cash Flow Growth for Neurotrope Inc 's Suppliers
Free Cash Flow Growth for NTRP's Customers

You may also want to know
NTRP's Annual Growth Rates NTRP's Profitability Ratios NTRP's Asset Turnover Ratio NTRP's Dividend Growth
NTRP's Roe NTRP's Valuation Ratios NTRP's Financial Strength Ratios NTRP's Dividend Payout Ratio
NTRP's Roa NTRP's Inventory Turnover Ratio NTRP's Growth Rates NTRP's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2020
Heartbeam Inc 32.89%$ 32.886 millions
Wright Medical Group N v 31.94%$ 31.945 millions
Stryker Corp31.80%$ 31.797 millions
Electromed Inc 30.67%$ 30.667 millions
Dentsply Sirona Inc 30.17%$ 30.170 millions
Innoviva Inc 29.89%$ 29.887 millions
Boston Scientific Corporation28.09%$ 28.088 millions
Abbvie inc 27.99%$ 27.991 millions
Mettler toledo International Inc 27.98%$ 27.975 millions
Hca Healthcare Inc 27.80%$ 27.799 millions
Musclepharm Corporation25.59%$ 25.592 millions
Horizon Therapeutics Public Limited Company24.39%$ 24.392 millions
Biomarin Pharmaceutical Inc22.93%$ 22.932 millions
3m Company22.65%$ 22.651 millions
Eli Lilly And Company19.63%$ 19.634 millions
Nuvasive Inc19.26%$ 19.265 millions
China Health Industries Holdings Inc 17.44%$ 17.437 millions
Cumberland Pharmaceuticals Inc16.70%$ 16.699 millions
Integrated Biopharma Inc13.83%$ 13.828 millions
Johnson and Johnson11.37%$ 11.372 millions
Zoetis Inc 11.07%$ 11.067 millions
West Pharmaceutical Services Inc 9.71%$ 9.713 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com